Proteomics

Dataset Information

0

Proteogenomic Landscape of Squamous Cell Lung Cancer 2: Tandem Mass Tag Datasets


ABSTRACT: We report an integrated analysis incorporating DNA copy number analyses, somatic exon mutations, mRNA expression via RNA-sequencing, and shotgun mass spectrometry analysis of protein abundance in 108 surgically resected squamous cell lung cancers (SCC) with accompanying clinical outcome, evaluation of tumor pathology, and other clinically relevant data. We identified three major subtypes of SCC at the proteomic level, with two groups associated with inflammation/immune response or oxidation-reduction biology. Inflamed tumors could be further sub-classified based on neutrophil infiltration or antigen presentation proteomes and reflected patterns of infiltrating immune cells. No gene mutations, mRNA signatures, or proteomic subclasses were associated with outcomes; however, the presence of B-cell rich tertiary lymph node structures could be associated with better patient outcomes. By integrating our proteogenomic data with publicly available RNA interference screen data, we identified TP63, PSAT1, and AKR1C3 as vulnerabilities in SCC, particularly in the redox proteomic group. This cohort and its deep molecular data serves as an important resource to better understand biology and targets associated with SCC.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Lung

DISEASE(S): Lung Squamous Cell Carcinoma

SUBMITTER: John Koomen  

LAB HEAD: Eric Haura, MD

PROVIDER: PXD010429 | Pride | 2019-05-24

REPOSITORIES: Pride

altmetric image

Publications


How genomic and transcriptomic alterations affect the functional proteome in lung cancer is not fully understood. Here, we integrate DNA copy number, somatic mutations, RNA-sequencing, and expression proteomics in a cohort of 108 squamous cell lung cancer (SCC) patients. We identify three proteomic subtypes, two of which (Inflamed, Redox) comprise 87% of tumors. The Inflamed subtype is enriched with neutrophils, B-cells, and monocytes and expresses more PD-1. Redox tumours are enriched for oxida  ...[more]

Similar Datasets

2019-08-19 | PXD013172 | Pride
2022-05-09 | PXD032270 | Pride
2021-08-11 | PXD023193 | Pride
2013-04-30 | E-GEOD-42677 | biostudies-arrayexpress
2008-12-30 | E-GEOD-14218 | biostudies-arrayexpress
2023-10-26 | PXD044064 | Pride
2023-04-27 | PXD040269 | Pride
2018-07-05 | PXD005301 | Pride
2010-06-21 | E-GEOD-15113 | biostudies-arrayexpress
2020-03-03 | PXD017025 | Pride